Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis

By Caretta-Weyer Holly   Greenberg Caprice   Wilke Lee   Weiss Jennifer   LoConte Noelle   Decker Marquita   Steffens Nicole   Smith Maureen   Neuman Heather  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4145-4152

Springer Publishing Company

Access to resources Recommend Favorite

Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

By Katz Matthew  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 337-344

Springer Publishing Company

Access to resources Recommend Favorite

From trial highlights to clinical context: putting American Society of Clinical Oncology gastrointestinal news into practice

By Aprile Giuseppe   Lutrino Stefania Eufemia   Sobrero Alberto  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 645-648

Future Medicine

Access to resources Recommend Favorite

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

By Hamaguchi Tetsuya  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 226-233

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite